Teladoc Health (TDOC) Depreciation & Amortization (CF) (2016 - 2025)
Teladoc Health's Depreciation & Amortization (CF) history spans 12 years, with the latest figure at $2.8 million for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) fell 6.04% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $13.3 million, up 30.75%, while the annual FY2025 figure was $13.3 million, 30.75% up from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $2.8 million at Teladoc Health, up from $2.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $94.3 million in Q3 2023 and bottomed at $1.7 million in Q2 2024.
- The 5-year median for Depreciation & Amortization (CF) is $50.0 million (2021), against an average of $36.3 million.
- The largest annual shift saw Depreciation & Amortization (CF) surged 418.96% in 2021 before it plummeted 97.74% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $52.3 million in 2021, then skyrocketed by 44.68% to $75.7 million in 2022, then plummeted by 96.31% to $2.8 million in 2023, then rose by 6.7% to $3.0 million in 2024, then decreased by 6.04% to $2.8 million in 2025.
- Per Business Quant, the three most recent readings for TDOC's Depreciation & Amortization (CF) are $2.8 million (Q4 2025), $2.6 million (Q3 2025), and $4.3 million (Q2 2025).